Future Oncology, Volume 14, Issue 14 (2018)

Browse this journal
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 14, Issue 14 (2018)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Volume 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Recent Breakthroughs in Metastatic Uveal Melanoma: A Cause for Optimism?
Joseph J Sacco, Helen Kalirai, Jenna Kenyani, Carlos R Figueiredo, Judy M Coulson & Sarah E Coupland
Pages: 1335-1338
Published online: 09 May 2018
AbstractforRecent Breakthroughs in Metastatic Uveal Melanoma: A Cause for Optimism? | Full Text | References | PDF (1.2 MB)
  • 3389 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Clinical Trial Protocol

Review Article
Phase III Study with FOLFIRI + Cetuximab Versus FOLFIRI + Cetuximab Followed by Cetuximab Alone in RAS and BRAF WT mCRC
Carmine Pinto, Nicola Normanno, Armando Orlandi, Francesca Fenizia, Angela Damato, Evaristo Maiello, Emiliano Tamburini, Francesco Di Costanzo, Giuseppe Tonini, Domenico Bilancia, Domenico Corsi, Salvatore Pisconti, Francesco Ferrau, Stefania Gori, Bruno Daniele, Alberto Zaniboni, Héctor Soto Parra, Giovanni Luca Frassinetti, Rosario Vincenzo Iaffaioli, Antonio Cassata, Maria Giulia Zampino, Lazzaro Repetto, Maria Alessandra Calegari, Carlo Barone & on behalf of all the investigators of ERMES study group.
Pages: 1339-1346
Published online: 30 May 2018
AbstractforPhase III Study with FOLFIRI + Cetuximab Versus FOLFIRI + Cetuximab Followed by Cetuximab Alone in RAS and BRAF WT mCRC | Full Text | References | PDF (1.4 MB)
  • 331 Views
  • 0 CrossRef citations
  • 0Altmetric

Short Communication

Brief Report
Negative Prognostic Factors and Resulting Clinical Outcome in Patients with Metastatic Renal Cell Carcinoma Included in the Italian Nivolumab-Expanded Access Program
Sergio Bracarda, Luca Galli, Marco Maruzzo, Giovanni Lo Re, Sebastiano Buti, Adolfo Favaretto, Francesco Di Costanzo, Cosimo Sacco, Marco Merlano, Claudia Mucciarini, Elena Zafarana, Sante Romito, Antonio Maestri, Carmelo G Giorgio, Maria T Ionta, Daniele Turci, Ugo De Giorgi, Giuseppe Procopio, Enrico Cortesi, Diana Giannarelli & Camillo Porta
Pages: 1347-1354
Published online: 18 May 2018
AbstractforNegative Prognostic Factors and Resulting Clinical Outcome in Patients with Metastatic Renal Cell Carcinoma Included in the Italian Nivolumab-Expanded Access Program | Full Text | References | PDF (1.4 MB)
  • 529 Views
  • 0 CrossRef citations
  • 0Altmetric

Research Article

Article
The Clinicopathological Features and Prognosis of Tumor MSI in East Asian Colorectal Cancer Patients Using NCI Panel
Jianmin Zheng, Bangxing Huang, Xiu Nie, Yan Zhu, Ningning Han & Yan Li
Pages: 1355-1364
Published online: 25 Jan 2018
AbstractforThe Clinicopathological Features and Prognosis of Tumor MSI in East Asian Colorectal Cancer Patients Using NCI Panel | Full Text | References | PDF (1.5 MB) | Supplemental
  • 231 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Expression and Prognostic Value of Mirna-29B in Peripheral Blood for Endometrial Cancer
Hui Wang, Tian-Tian Wang & Xiu-Ping Lv
Pages: 1365-1376
Published online: 31 May 2018
AbstractforExpression and Prognostic Value of Mirna-29B in Peripheral Blood for Endometrial Cancer | Full Text | References | PDF (1.5 MB)
  • 82 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Lactic Dehydrogenase to Albumin Ratio in Prediction of Unresectable Pancreatic Cancer with Intervention Chemotherapy
Shanshan Gao, Mengfei Wu, Yi Chen, Wenhui Lou, Guofeng Zhou, Junhao Li, Tianzhu Yu, Yang Zhou, Lingxiao Liu & Xiaolin Wang
Pages: 1377-1386
Published online: 31 May 2018
AbstractforLactic Dehydrogenase to Albumin Ratio in Prediction of Unresectable Pancreatic Cancer with Intervention Chemotherapy | Full Text | References | PDF (1.6 MB)
  • 112 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Hydration Requirements with Emetogenic Chemotherapy: Granisetron Extended-Release Subcutaneous Versus Palonosetron
Jeffrey Vacirca, Dennis Caruana, George Calcanes, Michael Mosier, Ralph Boccia & Ali McBride
Pages: 1387-1396
Published online: 09 Feb 2018
AbstractforHydration Requirements with Emetogenic Chemotherapy: Granisetron Extended-Release Subcutaneous Versus Palonosetron | Full Text | References | PDF (2.2 MB)
  • 1896 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
The Prognostic Analysis of Different Metastatic Patterns Extensive-Stage Small-Cell Lung Cancer Patients: A Large Population-Based Study
Hongchao Cai, Haiyong Wang, Zhenxiang Li, Jiamao Lin & Jinming Yu
Pages: 1397-1407
Published online: 23 Jan 2018
AbstractforThe Prognostic Analysis of Different Metastatic Patterns Extensive-Stage Small-Cell Lung Cancer Patients: A Large Population-Based Study | Full Text | References | PDF (2.9 MB)
  • 257 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Impact of Tumor Microenvironment Composition on Therapeutic Responses and Clinical Outcomes in Cancer
Fern Anari, Chethan Ramamurthy & Matthew Zibelman
Pages: 1409-1421
Published online: 31 May 2018
AbstractforImpact of Tumor Microenvironment Composition on Therapeutic Responses and Clinical Outcomes in Cancer | Full Text | References | PDF (2.9 MB)
  • 344 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Rates of febrile neutropenia and its causes in the real world
Maxime Borgeaud et al.
Article | Published online: 19 Jun 2024
Open Access
Efficacy and safety of triple or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis
Jingqi Jiang et al.
Review Article | Published online: 19 Jun 2024
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Evgeny Degtyarev et al.
Comment | Published online: 18 Jun 2024
Open Access
Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives
Elinor R Gatfield et al.
Comment | Published online: 18 Jun 2024
View all latest articles